These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 135124)
1. Malignant hyperthermia syndrome--evidence for denervation changes in human skeletal muscle. Heffron JJ; Isaacs H Klin Wochenschr; 1976 Sep; 54(18):865-7. PubMed ID: 135124 [TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle mitochondrial phospholipase A2 and the interaction of mitochondria and sarcoplasmic reticulum in porcine malignant hyperthermia. Cheah KS; Cheah AM Biochim Biophys Acta; 1981 Nov; 638(1):40-9. PubMed ID: 6117317 [No Abstract] [Full Text] [Related]
3. A review of the role of swine skeletal muscle in malignant hyperthermia. Campion DR; Topel DG J Anim Sci; 1975 Sep; 41(3):779-86. PubMed ID: 125736 [No Abstract] [Full Text] [Related]
4. Mitochondrial and plasma membrane changes in skeletal muscle in the malignant hyperthermia syndrome. Heffron JJ Biochem Soc Trans; 1984 Jun; 12(3):360-2. PubMed ID: 6734894 [No Abstract] [Full Text] [Related]
5. The effects of chlorbutol on skeletal muscle sarcoplasmic reticulum function in porcine malignant hyperpyrexia. Sim AT; White MD; Denborough MA Int J Biochem; 1987; 19(9):827-30. PubMed ID: 2961634 [TBL] [Abstract][Full Text] [Related]
6. Porcine malignant hyperthermia susceptibility: increased calcium-sequestering activity of skeletal muscle sarcoplasmic reticulum. O'Brien PJ Can J Vet Res; 1986 Jul; 50(3):329-37. PubMed ID: 3742368 [TBL] [Abstract][Full Text] [Related]
7. Morphological and biochemical defects in muscles of human carriers of the malignant hyperthermia syndrome. Isaacs H; Heffron JJ Br J Anaesth; 1975 Apr; 47(4):475-81. PubMed ID: 124580 [TBL] [Abstract][Full Text] [Related]
12. [Etiology of malignant hyperthermia]. Okumura F; Kuro M Masui; 1975 Jun; 24(6):525-37. PubMed ID: 169408 [No Abstract] [Full Text] [Related]
13. Etiopathogenetic defect of malignant hyperthermia: hypersensitive calcium-release channel of skeletal muscle sarcoplasmic reticulum. O'Brien PJ Vet Res Commun; 1987; 11(6):527-59. PubMed ID: 2453969 [No Abstract] [Full Text] [Related]
14. Experimental porcine malignant hyperthermia: the activity of certain transporting enzymes and myofibrillar calcium-binding protein content in the muscle fibre. Niebrój-Dobosz I; Mayzner-Zawadzka E Br J Anaesth; 1982 Aug; 54(8):885-91. PubMed ID: 6125163 [TBL] [Abstract][Full Text] [Related]
15. Editorial: Malignant hyperthermia: a pharmacogenetic disease of skeletal and cardiac muscle. Britt BA N Engl J Med; 1974 May; 290(20):1140-2. PubMed ID: 4274465 [No Abstract] [Full Text] [Related]
16. Total calcium content of skeletal muscle isolated from humans and pigs susceptible to malignant hyperthermia. Britt BA; Endrenyi L; Barclay RL; Cadman DL Br J Anaesth; 1975 Jun; 47(6):647-53. PubMed ID: 1148084 [TBL] [Abstract][Full Text] [Related]
17. Central-core disease and malignant hyperpyrexia. Denborough MA; Dennett X; Anderson RM Br Med J; 1973 Feb; 1(5848):272-3. PubMed ID: 4265427 [No Abstract] [Full Text] [Related]
19. 'Picture frame' fibres in a carrier of the trait for malignant hyperpyrexia. Isaacs H; Heffron JJ; Badenhorst M S Afr Med J; 1975 Nov; 49(46):1923-6. PubMed ID: 795 [TBL] [Abstract][Full Text] [Related]
20. Biochemical studies on malignant hyperpyrexia. Pennington RJ; Worsfold M Proc R Soc Med; 1973 Jan; 66(1 Pt 1):69-70. PubMed ID: 4266079 [No Abstract] [Full Text] [Related] [Next] [New Search]